HIV Drug Buyers Urge $3.6B Verdict Against Gilead And Teva
Gilead and Teva "cut a pay-off deal" to keep prices for two HIV drugs as "expensive as possible for as long as possible" and should be ordered to return overcharges totaling...To view the full article, register now.
Already a subscriber? Click here to view full article